The Bruton tyrosine kinase (BTK) inhibitor PCI‐32765 synergistically increases proteasome inhibitor activity in diffuse large‐B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
| Image |  |
|---|---|
| Description | scientific article published on January 30, 2013 |
| Author/s |
author: Paul Dent |
| Publication date | January 30, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.12206 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |